#Japan #Tokyo # #CBD #fuwari #Wellpharma

Introducing Wellpharma's fuwari and Its Impact on Femcare

On December 7, 2025, Wellpharma's femcare brand 'fuwari' participated in the 2nd Japanese Beauty Medical Conference, held at TODAHALL A in the Chuo Ward of Tokyo. This conference marks a significant intersection of aesthetics and medical care, with a focus on promoting healthy and beautiful living through medical education and advancements.

Conference Context

The Japanese Beauty Medical Conference aims to disseminate knowledge about the integration of aesthetic and internal medicine, establishing a platform for professionals in the field to share insights. Established in 2023, this conference highlights the importance of scientifically backed information in the growing fields of anti-aging and medical dieting.

Fuwari's participation stems from its commitment to evidence-based wellness care, aligning perfectly with the conference’s objectives of providing accurate information and promoting health.

The conference's president, Dr. Akira Aoki, who also serves as a medical supervisor for Wellpharma, emphasizes the importance of collaboration between medical professionals and product development, reinforcing Fuwari's ethos of integrating wellness into everyday life.

Exhibition Insights

The Fuwari exhibition booth drew considerable attention by featuring testers for various products, allowing attendees to experience the benefits firsthand. These demonstrations highlighted the product's moisturizing effects and compatibility with user skin types, fostering substantial interest from visiting professionals.

In addition, attendees engaged in enriching discussions that revolved around the scientific evidence, development process, and active ingredients of Fuwari's products. By presenting evidence-based research, Wellpharma aimed to clarify misconceptions around the use of CBD in wellness products.

Feedback from Medical Professionals

Attendees included numerous specialists who provided valuable insights:

• - Gynecologist: "Many consultations I receive involve dryness and issues in the delicate zone during perimenopause, and having a product for home care is incredibly appealing, especially if it circumvents pharmaceuticals."
• - Dermatologist: "I was under the impression that CBD products faced strict regulations, but learning that compliant products are viable has sparked my interest in pursuing these options."
• - Internist: "I had heard about CBD but was unaware of its extensive applications and mechanisms. This presentation significantly broadened my understanding."

Future Endeavors for fuwari

Fuwari is committed to enhancing the quality of life and health for women, addressing concerns such as the desire for improved well-being and prevention of diseases. By actively collaborating with medical professionals, the brand aims to create innovative solutions that cater to women’s wellness needs. Through continuous dialogue and feedback from experts, Fuwari hopes to expand its range of products that resonate with consumer desires for effective and holistic health solutions.

Company Profile

Wellpharma is on a mission to resolve physical and psychological challenges through evidence-based wellness care, maximizing lifelong health satisfaction. Their endeavors include the research and commercialization of new materials such as CBD, planning and manufacturing wellness care products for medical institutions, and engaging in OEM and wholesale of supplements and cosmetics.

Company Name: Wellpharma, Co., Ltd.
Headquarters: 5-26-12 Minamiooi, Shinagawa-ku, Tokyo, 140-0013, Japan
CEO: Kazuhiro Fukuda
Business Activities: Planning, development, and sale of health foods, cosmetics, and pet care products.
Official Website: Wellpharma